SEC Form D filing

Rani Therapeutics Holdings, Inc., 2025-11-10

An SEC Form D private-offering notice from San Jose, CA, a $60,255,052 filer-stated offering target in Biotech. Filed 2025-11-10. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Clinical stage biotherapeutics company developing the RaniPill robotic capsule for oral delivery of biologic drugs, publicly traded on Nasdaq as RANI.

Filed 2025-11-10Filed to raise $60,255,052First money in 2025-10-23Raised so far $60,255,052HQ (as filed) San Jose, CASector Biotech web-verified against the company’s own siteStage (inferred) GrowthCall status Call-ready
Source linked the Form D on EDGAR↗Website verified ranitherapeutics.com↗Named in the filing 9 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source